Research ExplorerScientific StaffThomas Stübig Publications

Dr.med. ID: 27512398

Thomas Stübig

graph of relations
Affiliations
1 - 21 out of 21Page size: 50

Publications

  1. 2024

  2. 67/m mit dekompensierter häuslicher Versorgung unter Erstlinientherapie beim metastasiertem kleinzelligem Bronchialkarzinom: Vorbereitung auf die Facharztprüfung: Fall 49

    Oechsle, K., Stübig, T., Coym, A., Schieferdecker, A. & Weidmann, J., 05.08.2024, In: ONKOLOGIE-GER. 30, p. 886–890 5 p.

    Research output: SCORING: Contribution to journal › Training articles › Education › peer-review

  3. 2015

  4. JAK1/2 inhibition impairs T cell function in vitro and in patients with myeloproliferative neoplasms

    Parampalli Yajnanarayana, S., Stübig, T., Cornez, I., Alchalby, H., Schönberg, K., Rudolph, J., Triviai, I., Wolschke, C., Heine, A., Brossart, P., Kröger, N. & Wolf, D., 30.03.2015, In: BRIT J HAEMATOL. 169, 6, p. 824-33

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. CD133 marks a stem cell population that drives human Primary Myelofibrosis

    Triviai, I., Stübig, T., Niebuhr, B., Hussein, K., Tsiftsoglou, A., Fehse, B., Stocking, C. & Kröger, N., 27.02.2015, In: HAEMATOLOGICA. 100, 6, p. 768-79

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  6. Atovaquone for Prophylaxis of Toxoplasmosis after Allogeneic Hematopoietic Stem Cell Transplantation.

    Mendorf, A., Klyuchnikov, E., Langebrake, C., Rohde, H., Ayuketang, F. A., Regier, M., Christopeit, M., Zabelina, T., Bacher, A., Stübig, T., Wolschke, C., Bacher, U. & Kroger, N., 2015, In: ACTA HAEMATOL-BASEL. 134, 3, p. 146-154

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. 2014

  8. JAK inhibition with ruxolitinib as pretreatment for allogeneic stem cell transplantation in primary or post-ET/PV myelofibrosis

    Stübig, T., Alchalby, H., Ditschkowski, M., Wolf, D., Wulf, G., Zabelina, T., Wolschke, C., Ayuketang, F. A. & Kröger, N., 01.08.2014, In: LEUKEMIA. 28, 8, p. 1736-8 3 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. Endogenous retrovirus induces leukemia in a xenograft mouse model for primary myelofibrosis

    Triviai, I., Ziegler, M., Bergholz, U., Oler, A. J., Stübig, T., Prassolov, V., Fehse, B., Kozak, C. A., Kröger, N-M. & Stocking, C., 10.06.2014, In: P NATL ACAD SCI USA. 111, 23, p. 8595 - 8600

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. Dynamic of bone marrow fibrosis regression predicts survival after allogeneic stem cell transplantation for myelofibrosis

    Kröger, N., Zabelina, T., Alchalby, H., Stübig, T., Wolschke, C., Ayuketang, F. A., von Huenerbein, N., Kvasnicka, H-M., Thiele, J., Kreipe, H-H. & Büsche, G., 01.06.2014, In: BIOL BLOOD MARROW TR. 20, 6, p. 812-5 4 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  11. 5-azacytidine promotes an inhibitory T-cell phenotype and impairs immune mediated antileukemic activity

    Stübig, T., Badbaran, A., Luetkens, T., Hildebrandt, Y., Atanackovic, D., Binder, T. M. C., Fehse, B. & Kröger, N-M., 13.03.2014, In: MEDIAT INFLAMM. 2014, p. 418292

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. CD34(+)-selected stem cell boost without further conditioning for poor graft function after allogeneic stem cell transplantation in patients with hematological malignancies

    Klyuchnikov, E., El-Cheikh, J., Sputtek, A., Lioznov, M., Calmels, B., Furst, S., Chabannon, C., Crocchiolo, R., Lemarié, C., Faucher, C., Bacher, U., Alchalby, H., Stübig, T., Wolschke, C., Ayuketang, F. A., Reckhaus, M-L., Blaise, D. & Kröger, N-M., 01.03.2014, In: BIOL BLOOD MARROW TR. 20, 3, p. 382-6 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. Allogeneic stem cell transplantation for myelofibrosis with leukemic transformation: a study from the Myeloproliferative Neoplasm Subcommittee of the CMWP of the European Group for Blood and Marrow Transplantation

    Alchalby, H., Zabelina, T., Stübig, T., van Biezen, A., Bornhäuser, M., Di Bartolomeo, P., Beelen, D., Cahn, J. Y., Dreger, P., Schroyens, W., de Witte, T., Olavarria, E., Kröger, N. & Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation (EBMT), 01.02.2014, In: BIOL BLOOD MARROW TR. 20, 2, p. 279-81 3 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  14. Immune-modulating drugs and hypomethylating agents to prevent or treat relapse after allogeneic stem cell transplantation

    Kröger, N., Stübig, T. & Atanackovic, D., 01.02.2014, In: BIOL BLOOD MARROW TR. 20, 2, p. 168-72 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  15. 2013

  16. Comparative diagnostic performance of ¹⁸F-FDG PET/CT versus whole-body MRI for determination of remission status in multiple myeloma after stem cell transplantation

    Derlin, T., Peldschus, K., Münster, S., Bannas, P., Herrmann, J., Stübig, T., Habermann, C. R., Adam, G., Kröger, N-M. & Weber, C., 01.02.2013, In: EUR RADIOL. 23, 2, p. 570-8 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  17. Impact of high-risk cytogenetics and achievement of molecular remission on long-term freedom from disease after autologous-allogeneic tandem transplantation in patients with multiple myeloma.

    Kröger, N-M., Badbaran, A., Zabelina, T., Ayuketang, F. A., Wolschke, C., Alchalby, H., Klyuchnikov, E., Atanackovic, D., Schilling, G., Hansen, T., Schwarz, S., Heinzelmann, M., Zeschke, S., Bacher, U., Stübig, T., Fehse, B. & Zander, A. R., 2013, In: BIOL BLOOD MARROW TR. 19, 3, p. 398-404 7 p., 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  18. Outcome of allogeneic SCT in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy.

    Oyekunle, A., Zander, A. R., Binder, M., Ayuketang, F. A., Zabelina, T., Christopeit, M., Stübig, T., Alchalby, H., Schafhausen, P., Lellek, H., Wolschke, C., Müller, I., Bacher, U. & Kröger, N-M., 2013, In: ANN HEMATOL. 92, 4, p. 487-496 10 p., 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  19. Postallograft lenalidomide induces strong NK cell-mediated antimyeloma activity and risk for T cell-mediated GvHD: Results from a phase I/II dose-finding study.

    Wolschke, C., Stübig, T., Hegenbart, U., Schönland, S., Heinzelmann, M., Hildebrandt, Y., Ayuketang Ayuk, F., Atanackovic, D., Dreger, P., Zander, A. & Kröger, N., 2013, In: EXP HEMATOL. 41, 2, p. 133-134 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  20. Toxicity-reduced, myeloablative allograft followed by lenalidomide maintenance as salvage therapy for refractory/relapsed myeloma patients.

    Kröger, N., Zabelina, T., Klyuchnikov, E., Kropff, M., Pflüger, K-H., Burchert, A., Stübig, T., Wolschke, C., Ayuketang, F. A., Hildebrandt, Y., Bacher, U., Badbaran, A., Schilling, G., Hansen, T., Atanackovic, D. & Zander, A. R., 2013, In: BONE MARROW TRANSPL. 48, 3, p. 403-407 5 p., 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  21. 2012

  22. Diagnostic performance of whole-body MRI for the detection of persistent or relapsing disease in multiple myeloma after stem cell transplantation.

    Bannas, P., Hentschel, H. B., Bley, T., Treszl, A., Zu Eulenburg, C. G., Derlin, T., Yamamura, J., Adam, G., Stübig, T., Kröger, N. & Weber, C., 2012, In: EUR RADIOL. 22, 9, p. 2007-2012 9.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  23. Impact of the NK cell receptor LIR-1 (ILT-2/CD85j/LILRB1) on cytotoxicity against multiple myeloma.

    Heidenreich, S., Zu Eulenburg, C. G., Hildebrandt, Y., Stübig, T., Sierich, H., Badbaran, A., Eiermann, T., Binder, T. & Kröger, N., 2012, In: Clin Dev Immunol. 2012, p. 652130

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  24. 2011

  25. Purification of CD4+ T cells for adoptive immunotherapy after allogeneic hematopoietic stem cell transplantation

    Klyuchnikov, E., Sputtek, A., Slesarchuk, O., Lioznov, M., Stübig, T., Bacher, U., Amtsfeld, G., Merle, E., Reckhaus, M-L., Fehse, B., Wolschke, C., Adjalle, R., Ayuketang Ayuk, F., Zander, A. R. & Kröger, N., 01.03.2011, In: BIOL BLOOD MARROW TR. 17, 3, p. 374-383 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  26. Circulating CD34(+) cells as prognostic and follow-up marker in patients with myelofibrosis undergoing allo-SCT.

    Alchalby, H., Lioznov, M., Fritzsche-Friedland, U., Badbaran, A., Zabelina, T., Bacher, U., Stübig, T., Ayuketang Ayuk, F., Zander, A. R. & Kröger, N., 2011, In: BONE MARROW TRANSPL. 47, 1, p. 143-145 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  27. Donor KIR haplotype B improves progression-free and overall survival after allogeneic hematopoietic stem cell transplantation for multiple myeloma.

    Kröger, N., Zabelina, T., Berger, J., Duske, H., Klyuchnikov, E., Binder, T., Stübig, T., Hildebrandt, Y., Atanackovic, D., Alchalby, H., Ayuketang Ayuk, F., Zander, A. R., Bacher, U. & Eiermann, T., 2011, In: LEUKEMIA. 25, 10, p. 1657-1661 10.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review